Helius Medical has raised over $500 million in an oversubscribed offering to launch a solana-focused treasury vehicle, positioning SOL as its primary reserve asset with plans to leverage its yield and onchain growth.
Helius Secures Over $500 Million to Build Solana Treasury
WRITTEN BY
SHARE
Pantera Capital and Summer Capital Back Helius With Key Funding for Solana Treasury
Helius Medical Technologies (Nasdaq: HSDT) has announced over $500 million in funding to launch a solana-backed treasury strategy, in partnership with Pantera Capital and Summer Capital. The initiative aims to create a preeminent solana treasury vehicle while unlocking capital markets to further accelerate solana’s growth.
The oversubscribed private investment in public equity (PIPE) was priced at $6.881 per share, with stapled warrants exercisable at $10.134. Helius intends to use the proceeds to acquire SOL as its primary reserve asset, leveraging its native staking yield and broader defi opportunities.
“A productive treasury company, backing the industry’s most affordable, fastest, and most accessible network, stands to substantially increase institutional and retail access to the solana ecosystem and help fuel its adoption around the world,” said Dan Morehead, Founder of Pantera Capital.
A broad coalition of institutional and crypto-native investors backed the deal, including Big Brain Holdings, Arrington Capital, Animoca Brands, FalconX, Borderless, Hashkey Capital, and Republic Digital.
Solana’s network fundamentals remain strong, with 3.7 million daily active wallets, over 23 billion transactions year-to-date, and throughput above 3,500 transactions per second.
